RAC 0.60% $1.69 race oncology ltd

General Comments / Chat, page-8640

  1. 1,246 Posts.
    lightbulb Created with Sketch. 2461
    Yes. But if measuring before, during, and after is only one part of the needed validation, and you need to show an objective response to the cancer. As per above response.

    Then Sheba 2 wont provide the validation we need being combo treatment.

    It will provide insight & beneficial data, just not clinical validation of FTO.

    If only Sheba 1 came after COH findings.


 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
(20min delay)
Last
$1.69
Change
0.010(0.60%)
Mkt cap ! $287.1M
Open High Low Value Volume
$1.69 $1.70 $1.65 $89.01K 53.2K

Buyers (Bids)

No. Vol. Price($)
1 2342 $1.69
 

Sellers (Offers)

Price($) Vol. No.
$1.70 5 1
View Market Depth
Last trade - 16.10pm 13/09/2024 (20 minute delay) ?
RAC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.